Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues

被引:16
|
作者
Turman, Cheri M.
Hatley, Jade M.
Ryder, Daniel J.
Ravindranath, Vijayalakshmi
Strobel, Hen W.
机构
[1] Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Natl Brain Res Ctr, Manesar, Haryana, India
关键词
alternative splicing; brain CYPs; cytochrome P450; drug metabolism;
D O I
10.1517/17425255.2.3.399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human cytochrome P450 (CYP) superfamily of enzymes regulate hepatic phase 1 drug metabolism and subsequently play a significant role in pharmacokinetics, drug discovery and drug development. Alternative splicing of the cytochrome CYP gene transcripts enhances gene diversity and may play a role in transcriptional regulation of certain CYP proteins. Tissue-specific alternative splicing of CYPs is significant for its potential to add greater dimension to differential drug metabolism in hepatic and extrahepatic tissues, such as the brain, and to our understanding of the CYP family. This review provides an overview of tissue-specific splicing patterns, splicing types, regulation and the functional diversities between liver and splice variant CYP proteins and further explores the relevance of tissue-specific alternative splicing of CYPs in the nervous system.
引用
收藏
页码:399 / 418
页数:20
相关论文
共 50 条
  • [21] Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes
    Lou, Dan
    Bao, Su-su
    Li, Ying-hui
    Lin, Qian-meng
    Yang, Su-fen
    He, Jia-yang
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (05) : 611 - 618
  • [22] Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases
    Johnson, EF
    Stout, CD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (01) : 331 - 336
  • [23] Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma
    Schmidt, Andreas
    Braeuning, Albert
    Ruck, Peter
    Seitz, Guido
    Armeanu-Ebinger, Sorin
    Fuchs, Joerg
    Warmann, Steven W.
    Schwarz, Michael
    TOXICOLOGY, 2011, 281 (1-3) : 7 - 14
  • [24] Bioconversion of Mono- and Sesquiterpenoids by Recombinant Human Cytochrome P450 Monooxygenases
    Julsing, Mattijs K.
    Fichera, Mario A.
    Malz, Frank
    Ebbelaar, Monique
    Bos, Rein
    Woerdenbag, Herman J.
    Quax, Wim J.
    Kayser, Oliver
    PHARMACEUTICAL BIOLOGY, 2008, 46 (10-11) : 710 - 718
  • [25] Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2
    Guo, Jingchao
    Zhu, Xiaohui
    Badawy, Sara
    Ihsan, Awais
    Liu, Zhenli
    Xie, Changqing
    Wang, Xu
    CURRENT DRUG METABOLISM, 2021, 22 (01) : 40 - 49
  • [26] Screening of the whole human cytochrome P450 complement (CYPome) with enzyme bag cocktails
    Sharma, Sangeeta Shrestha
    Sharma, Shishir
    Bureik, Matthias
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2020, 10 (03) : 271 - 276
  • [27] Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method
    Gao, Jing
    Zhang, Yuanjin
    Lei, Xueqin
    Xu, Yuan
    Sun, Zhenliang
    Wang, Xin
    TOXICOLOGY IN VITRO, 2022, 79
  • [28] Melatonin Activation by Human Cytochrome P450 Enzymes: A Comparison between Different Isozymes
    Mokkawes, Thirakorn
    De Visser, Tamar
    Cao, Yuanxin
    De Visser, Sam P.
    MOLECULES, 2023, 28 (19):
  • [29] Characterization of the metabolism of eupalinolide A and B by carboxylesterase and cytochrome P450 in human liver microsomes
    Li, Yingzi
    Liu, Xiaoyan
    Li, Ludi
    Zhang, Tao
    Gao, Yadong
    Zeng, Kewu
    Wang, Qi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Roles of human cytochrome P450 enzymes involved in drug metabolism and toxicological studies
    Yamazaki, H
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (12): : 1347 - 1357